TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
VSTM

Verastem Inc

Healthcare · Biotechnology

8.00$ +7.4% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement VSTM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
2.2% 16.1% 38.1% 10.0% 4.5% 0.3% 17.1%
97.8% 83.9% 61.9% 100.0% 100.0% 100.0% 82.9%
163.4% 262.2% 46.7% 1,916.6% 1,947.5% 813.3% 370.7%
289.2% 579.8% 70.9% 1,174.6% 962.1% 436.2% 262.5%
452.6% 842.1% 117.6% 3,091.2% 2,909.6% 1,249.6% 633.2%
-354.8% -758.1% -55.8% -2,991.2% -2,809.6% -1,149.6% -550.3%
21.7% 118.1% 17.8% 485.7% 82.3% 45.6% 3.7%
-271.1% -854.8% -76.3% -3,468.1% -2,843.3% -1,304.5% -677.6%
105.4% 114.4% 0.2% 482.2% 1.4% 1.8%
-271.1% -854.8% -76.5% -3,468.1% -2,843.3% -1,306.4% -677.6%
-244.0% -724.2% -57.0% -2,978.9% -2,756.4% -1,258.6% -671.6%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?